| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 09/12/2007 | EP1831183A1 1,6-substituted (3r,6r)-3-(2,3-dihydro-1h-inden-2-yl)-2,5-piperazinedione derivatives as oxytocin receptor antagonists for the treatment of pre-term labour, dysmenorrhea and endometriosis |
| 09/12/2007 | CN101035783A Urea derivatives as calcium channel blockers |
| 09/12/2007 | CN101035767A Substituted phenylacetamides and their use as glucokinase activators |
| 09/11/2007 | US7268164 Administering an amino carbonyl compound |
| 09/11/2007 | US7268140 (2S)-1-((4-chlorophenoxy)methyl)carbonyl-2-methyl-4-(4-fluorobenzyl)piperazine; inhibit the activity of the chemokines, MIP-1 alpha and RANTES |
| 09/11/2007 | US7268127 Azaindoles having serotonin receptor affinity |
| 09/11/2007 | CA2318368C Novel tricyclic compound |
| 09/07/2007 | WO2007100852A1 Therapeutic piperazines as pde4 inhibitors |
| 09/07/2007 | WO2007099385A1 Dipeptidyl peptidase iv inhibitor compounds and compositions |
| 09/07/2007 | WO2007060144A3 Novel quinoxaline derivatives and their medical use |
| 09/07/2007 | WO2007042788A3 Acenaphthoquinoxaline sulfonamide derivatives, optical crystal film and method of production thereof |
| 09/07/2007 | CA2644069A1 Therapeutic piperazines as pde4 inhibitors |
| 09/06/2007 | US20070208032 Chemical compounds |
| 09/06/2007 | US20070208019 Vasculostatic agents and methods of use thereof |
| 09/06/2007 | US20070208008 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 09/05/2007 | EP1829856A2 Transfection reagents |
| 09/05/2007 | EP1828154A1 Phenyl-piperazin methanone derivatives |
| 09/05/2007 | EP1828147A1 Quinoxalines as b-raf inhibitors |
| 09/05/2007 | EP1828118A1 Parp inhibitors |
| 09/05/2007 | EP1663995B1 Sulfoderivatives of acenaphtho [1,2-b]quinoxaline, lyotropic liquid crystal and anisotropic film on their base |
| 09/05/2007 | EP0993452B1 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 09/05/2007 | CN101031539A Substituted arylalkanoic acid derivatives and use thereof |
| 09/05/2007 | CN100335483C Double piperazine quaternary ammonium salt compound with analgetic function |
| 09/05/2007 | CN100335468C Diaryl amidine compound, its production, medicinal composition and use |
| 09/04/2007 | US7265378 Light emitting diodes |
| 09/04/2007 | US7265223 2-chloroacetamide-N-methyl-2-phenylacetamide chemical intermediates for making 3-phenyl-1-methylpiperazine (new intermediate for mirtazapine), by cyclization; nontoxic, efficiency |
| 09/04/2007 | US7265130 anti-obestic activity; Neuropeptide Y antagonist |
| 09/04/2007 | US7265119 For therapy of nicotine dependency |
| 09/04/2007 | US7265108 For example, 6-[2-[4-(2-fluorophenoxymethyl)piperidino]ethyl]-1H-pyrazin-2-one; therapeutic or prophylactic agent for diabetic neuralgia, HIV neuralgia, postherpetic neuralgia, nerve system disorders |
| 09/04/2007 | CA2258044C Muscarinic antagonists |
| 09/04/2007 | CA2239174C Novel compounds with analgesic effect |
| 08/30/2007 | WO2007096193A2 Radiolabelled carbamates |
| 08/30/2007 | US20070203337 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 08/30/2007 | US20070203207 Heteroaromatic glucokinase activators |
| 08/30/2007 | US20070203205 treatment and/or prevention of adverse conditions of the central nervous system, including sleep disorders such as insomnia, psychotic disorders such as schizophrenia and psychiatric disorders such as anxiety; example (1S)-1-[2-({4-[(E)-2-(4-fluorophenyl)vinyl]phenyl}sulfonyl)phenyl]ethanol |
| 08/30/2007 | US20070203139 Aryl Glycinamide Derivatives And Their Use As Nk1 Antagonists And Serotonin Reuptake Inhibitors |
| 08/30/2007 | US20070203131 Bis-aryl sulfonamides |
| 08/30/2007 | US20070202600 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 08/30/2007 | US20070202598 New transfection reagents |
| 08/29/2007 | EP1824856A1 2,4 (4,6) pyrimidine derivatives |
| 08/29/2007 | EP1824836A2 2-alkyl-cycloalk(en)yl-carboxamides |
| 08/29/2007 | EP1824817A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 08/28/2007 | US7262305 has optical properties with films that are significantly thinner |
| 08/28/2007 | US7262211 Activity as non-covalent inhibitors of urokinase and having activity in reducing or inhibiting blood vessel formation are provided. These compounds have at a group having a guanidino moiety or derivative thereof. These compounds are useful for |
| 08/23/2007 | WO2007095424A1 Novel tricyclic dihydropyrazines as potassium channel openers |
| 08/23/2007 | WO2007093963A1 Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives |
| 08/23/2007 | WO2007093507A1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes |
| 08/23/2007 | US20070197785 Providing compound selected from the group consisting of (meth)acrylic acid and its esters; adding an amount of a polymerization inhibitor to product, to inhibit polymerization of product and polymerization inhibitor comprising reduced halide-content azine dye-based compound |
| 08/23/2007 | US20070197522 Dpp-iv inhibitors |
| 08/23/2007 | US20070194698 Charge transport compositions and electronic devices made with such compositions |
| 08/23/2007 | CA2642212A1 Novel tricyclic dihydropyrazines as potassium channel openers |
| 08/23/2007 | CA2635205A1 Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives |
| 08/22/2007 | EP1819684A1 Substituted piperazines as cb1 antagonists |
| 08/22/2007 | EP1572670B1 5-substituted-pyrazine or -pyridine glucokinase activators |
| 08/22/2007 | EP1136470B1 Process for the preparation of a piperazine derivative |
| 08/22/2007 | CN1332939C Novel compounds inhibiting factor Xa activity |
| 08/22/2007 | CN1332921C Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| 08/22/2007 | CN101023064A Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors |
| 08/22/2007 | CN101023063A Azine-carboxamides as anti-cancer agent |
| 08/22/2007 | CN101022806A Use of (4-alkylpiperazinyl)(phenyl) methanones in the treatment of alzheimer's disease |
| 08/21/2007 | US7259186 Salts of fenofibric acid and pharmaceutical formulations thereof |
| 08/21/2007 | US7259179 Kinase inhibitors |
| 08/21/2007 | US7259166 Substituted-cycloalkyl and oxygenated-cycloalkyl glucokinase activators |
| 08/21/2007 | US7259163 Viricides against herpes virus |
| 08/21/2007 | US7259157 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists |
| 08/16/2007 | WO2007090434A1 Substituted aryl oximes |
| 08/16/2007 | WO2007041365B1 3-cyclyl-2- (4-sulfamo yl-phenyl) -n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes |
| 08/16/2007 | WO2006084688A8 HIV protease inhibitors |
| 08/16/2007 | US20070191392 Dipeptide nitrile cathespin k inhibitors |
| 08/16/2007 | US20070191383 Mtp inhibiting aryl piperydines or piperazines substituted with 5-membered heterocycles |
| 08/16/2007 | US20070191382 potassium channel modulators; 3-(4,6-Dioxo-2,3,4,6,7,8,9,10-octahydro-1H-phenazin-5-yl)-benzonitrile; urinary incontinence, overactive bladder, hypertension, erectile dysfunction, sexual disorders, dysmenorrhea, irritable bowel syndrome, epilepsy, stroke, Alzheimer's and Parkinson's diseases |
| 08/16/2007 | US20070191380 Kinase inhibitor scaffolds and methods for their preparation |
| 08/15/2007 | EP1818326A1 Nitrogen-containing heterocyclic compounds and pharmaceutical composition containing the compounds |
| 08/15/2007 | EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 08/15/2007 | EP1817294A1 1,2,3,4-tetrahydropyrazin-2-yl acetamides and their use as bradykinin antagonists for the treatment of inflammation related disorders |
| 08/15/2007 | EP1817282A1 Phenoxyacetic acid derivatives useful for treating respiratory diseases |
| 08/15/2007 | EP1322596B1 Zwitterionic tachykinin receptor antagonists |
| 08/15/2007 | CN1331862C Di-aryl acid derivatives as PPAR receptor ligands |
| 08/15/2007 | CN1331848C Tricyclic steroid hormone nuclear receptor modulators |
| 08/15/2007 | CN101018783A Quinoxaline inhibitors of the HEDGEHOG signalling pathway |
| 08/15/2007 | CN101018781A Bicyclic N-anilide spirolactam CGRP receptor antagonists |
| 08/15/2007 | CN101016268A Chemical synthesis method for 2-formylcyanoacetylhydrazone-quinoxaline-1,4-dioxide |
| 08/15/2007 | CN101016267A Chemical synthesis method for 3-methylquinoxaline-2-carboxylic acid |
| 08/14/2007 | US7256194 Compounds that inhibit factor Xa activity |
| 08/09/2007 | WO2007044729A3 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors |
| 08/09/2007 | WO2007021990A3 Melanocortin receptor-specific piperazine compounds with diamine groups |
| 08/09/2007 | US20070185162 Substituted diketopiperazines as oxytocin receptor antagonists |
| 08/09/2007 | US20070185128 Compounds and compositions for treating obesity |
| 08/09/2007 | US20070185127 2-(Arylalkoxy)-1-phenylethylamine derivatives as nk1 antagonist and serotonin reuptake inhibitors |
| 08/09/2007 | CA2635531A1 Multicyclic amino acid derivatives and methods of their use |
| 08/08/2007 | EP1678180B1 Substituted 2h-[1,2,4]triazolo 4,3-a pyrazines as gsk-3 inhibitors |
| 08/08/2007 | EP1349962A4 Methods and compositions for detecting polynucleotide duplex damage |
| 08/08/2007 | CN1330657C Novel piperidine and piperazine derivatives |
| 08/08/2007 | CN101014589A Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 08/08/2007 | CN101014577A Substituted amide beta secretase inhibitors |
| 08/08/2007 | CN101014565A Diarylsulfones as 5-HT2a antagonists |
| 08/08/2007 | CN101012202A Method of preparing 3-methylquinoxaline-2-carboxylic acid |
| 08/08/2007 | CN101012201A Ligustrazine derivative, preparation method and medical use thereof |
| 08/07/2007 | US7253205 Neurokinin 1 (NK-1) receptor antagonists; depression, anxiety, pain, inflammation, migraine, emesis, postherpetic neuralgia |
| 08/07/2007 | US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid |